NCT06961786
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06961786
Title TNFa and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy and TILs in the Treatment of Melanoma (TUNINTIL-2)
Acronym TUNINTIL-2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TILT Biotherapeutics Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries DNK


No variant requirements are available.